Levetiracetam Puren (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal membranes and decreases excessive neuronal excitability, thereby lowering the likelihood of seizure initiation and spread within the central nervous system.

The appropriate dose of Levetiracetam Puren is determined by the prescribing healthcare professional based on the patient’s age, renal function, seizure type, and response to therapy. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy are limited, and the drug is classified as having an unknown pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Levetiracetam Puren.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a favorable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for its broad spectrum of activity across seizure types and its ease of dosing, though individual response varies.

Levetiracetam Puren should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight to maintain stability.

Levetiracetam Puren is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with water and not chewed or crushed unless specifically advised.

Serious risks include severe allergic reactions (e.g., rash, swelling, breathing difficulty), mood changes such as depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they experience any of these symptoms.

Levetiracetam Puren is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications without proper monitoring.